Capital Fund Management (CFM)
NVO

Capital Fund Management (CFM)’s Novo Nordisk NVO Stock Holding History

Capital Fund Management (CFM)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-549,373
Closed -$23.6M – 2293
2026
Q1 		$20.2M Buy
549,373
+413,171
+303% +$19.6M 0.09% 307
2025
Q4 		$6.93M Sell
136,202
-98,540
-42% -$5.04M 0.02% 1014
2025
Q3 		$13M Buy
+234,742
New +$13.7M 0.03% 701
2025
Q2 		– Sell
-741,731
Closed -$50.5M – 2470
2025
Q1 		$51.5M Buy
741,731
+17,381
+2% +$1.44M 0.15% 196
2024
Q4 		$62.3M Buy
724,350
+237,950
+49% +$25.7M 0.16% 182
2024
Q3 		$57.9M Buy
486,400
+65,390
+16% +$8.72M 0.16% 169
2024
Q2 		$60.1M Sell
421,010
-348,006
-45% -$46.1M 0.18% 162
2024
Q1 		$98.7M Buy
769,016
+243,565
+46% +$29M 0.29% 68
2023
Q4 		$54.4M Buy
525,451
+310,478
+144% +$30.7M 0.15% 181
2023
Q3 		$19.5M Buy
+214,973
New +$18.9M 0.07% 361
2022
Q4 		– Sell
-22,378
Closed -$1.11M – 1556
2022
Q3 		$1.11M Sell
22,378
-53,952
-71% -$2.89M 0.01% 1053
2022
Q2 		$4.25M Buy
76,330
+55,850
+273% +$3.1M 0.04% 559
2022
Q1 		$1.14M Buy
+20,480
New +$1.05M 0.01% 1124
2021
Q4 		– Sell
-25,520
Closed -$1.38M – 1773
2021
Q3 		$1.23M Buy
25,520
+626
+3% +$30.3K 0.01% 1118
2021
Q2 		$1.04M Sell
24,894
-610
-2% -$23.6K 0.01% 1148
2021
Q1 		$860K Sell
25,504
-400
-2% -$14.2K 0.01% 1007
2020
Q4 		$905K Sell
25,904
-24,134
-48% -$834K 0.01% 1018
2020
Q3 		$1.74M Sell
50,038
-3,926
-7% -$131K 0.02% 678
2020
Q2 		$1.77M Sell
53,964
-247,764
-82% -$7.91M 0.03% 538
2020
Q1 		$9.08M Sell
301,728
-55,460
-16% -$1.65M 0.14% 193
2019
Q4 		$10.3M Sell
357,188
-125,830
-26% -$3.48M 0.08% 317
2019
Q3 		$12.5M Sell
483,018
-339,530
-41% -$8.59M 0.11% 247
2019
Q2 		$21M Sell
822,548
-216,608
-21% -$5.35M 0.19% 142
2019
Q1 		$27.2M Sell
1,039,156
-157,380
-13% -$3.87M 0.24% 112
2018
Q4 		$27.6M Buy
1,196,536
+52,720
+5% +$1.17M 0.24% 92
2018
Q3 		$27M Buy
1,143,816
+233,494
+26% +$5.7M 0.15% 177
2018
Q2 		$21M Buy
910,322
+149,574
+20% +$3.55M 0.11% 259
2018
Q1 		$18.7M Sell
760,748
-69,924
-8% -$1.84M 0.11% 261
2017
Q4 		$22.3M Buy
830,672
+390,302
+89% +$9.93M 0.12% 206
2017
Q3 		$10.6M Buy
440,370
+17,014
+4% +$384K 0.08% 314
2017
Q2 		$9.08M Buy
423,356
+249,966
+144% +$5.04M 0.07% 312
2017
Q1 		$2.97M Sell
173,390
-888,586
-84% -$15.5M 0.02% 630
2016
Q4 		$19M Buy
1,061,976
+702,338
+195% +$12.7M 0.16% 174
2016
Q3 		$7.48M Buy
359,638
+318,424
+773% +$7.89M 0.07% 337
2016
Q2 		$1.11M Sell
41,214
-10,374
-20% -$284K 0.01% 925
2016
Q1 		$1.4M Buy
+51,588
New +$1.38M 0.01% 793
2015
Q2 		– Sell
-247,228
Closed -$6.6M – 1637
2015
Q1 		$6.6M Sell
247,228
-328
-0.1% -$7.55K 0.09% 273
2014
Q4 		$5.24M Buy
+247,556
New +$5.53M 0.06% 431
2014
Q3 		– Sell
-22,872
Closed -$528K – 1726
2014
Q2 		$528K Buy
+22,872
New +$505K 0.01% 1198
2014
Q1 		– Sell
-318,400
Closed -$5.88M – 1886
2013
Q4 		$5.88M Buy
+318,400
New +$5.55M 0.07% 335
2013
Q3 		– Sell
-513,910
Closed -$7.96M – 1801
2013
Q2 		$7.96M Buy
+513,910
New +$8.55M 0.12% 206

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital Fund Management (CFM)'s NVO Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 549,373 shares — an estimated $23.6M sold.

Capital Fund Management (CFM) first reported a position in NVO in Q2 2013 and held it in 41 quarters. The position peaked at $98.7M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 549,373 Novo Nordisk shares in Q2 2026, an estimated $23.6M.
  • Capital Fund Management (CFM) first reported a position in Novo Nordisk in Q2 2013 and held it in 41 quarters.
  • Capital Fund Management (CFM)'s Novo Nordisk position peaked at $98.7M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.